NeoGenomics

NeoGenomics tests tumor tissue or blood for gene changes that may inform treatment and trial discussions. Your doctor orders the test; tissue and blood versions read different things.

Tests
PanTracer Tissue and Pro read tumor DNA/RNA. PanTracer LBx profiles tumor DNA from blood without RNA sequencing.[1]
Samples
Tumor tissue or blood, depending on the exact PanTracer test. Your care team arranges testing.[1][2]
Access
A doctor must order the test. Some PanTracer versions are not approved for use in New York; confirm the exact version.[2][1]
Cost
As of October 2026, no fixed PanTracer patient price was found on the pages checked. Insurance support, financial assistance and payment plans are available.[3]

NeoGenomics tests tumor tissue or blood for changes that may help your doctor discuss treatments and clinical trials. Ask which test is being ordered. Its panels do different jobs.

What they do

PanTracer Tissue reads tumor DNA and RNA. PanTracer Pro adds protein and other tests selected for the cancer type. PanTracer LBx looks at tumor DNA in blood; it does not sequence RNA.

These tests look for changes relevant to treatment selection. They are different from a test designed to watch for cancer returning.

Who it's for

The PanTracer portfolio serves people with advanced solid tumors. NeoGenomics also offers other tests for blood cancers. Sample needs and availability depend on the exact test and location. Some PanTracer versions are not approved for use in New York.

How to start

Your doctor orders the test and arranges the sample. Results go back to the doctor. Ask for your own copy of the full report.

Cost and insurance

As of October 2026, the pages checked did not list a fixed PanTracer patient price. NeoGenomics offers insurance support, financial assistance and payment plans. Ask for your expected bill before testing starts.

Other options

Caris, Tempus and Foundation Medicine also offer tumor profiling. Compare the actual test, sample and RNA coverage, rather than choosing by company name alone.

What to ask

  1. Which PanTracer test answers the decision we are facing?
  2. Does it include RNA testing, and is there enough tissue?
  3. If blood testing finds nothing useful, should we test tissue too?
  4. Is this version available where I live, and what will I owe?

A genomic result can raise treatment options. It does not guarantee that a treatment will work or that you qualify for a trial.

Contacts

Services & who they help

Company